Endava is trading at $1.83 with a -6.63% change in pre-market after disclosing it will restate fiscal 2026 results.
- On October 28, 2026, an investigation found errors in accounting for certain customer-supplier agreements; estimated revenue adjustments equal approximately 2%–4% of fiscal 2025 revenue.
- Endava said affected interim results and prior guidance should no longer be relied upon, and it expects to miss its November 2 annual-report filing deadline.